Fedor Tumusov, the First Deputy Chairman of the Health Protection Committee of the State Duma in Russia, has expressed his appreciation for the mandatory labeling of electronic cigarettes and their liquids in the Russian Federation starting from November 1. He added that thanks to the labeling, it will be possible to control the flow, sales, and quality of goods.
According to him, this innovation will assist in formulating measures to curb the spread of nicotine products and electronic cigarettes. Currently, it is unclear where e-cigarettes are manufactured, who supplies them, and how they are sold, and the labels will play a significant role in these aspects.
Statement
This article is a compilation of third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS and we are unable to confirm the authenticity or accuracy of its content. The translation of this article is intended for internal industry communication and research purposes only.
Due to limitations in translation ability, the translation may not accurately convey the same meaning as the original article. Please refer to the original article for accuracy.
Regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions, 2FIRSTS remains fully aligned with the Chinese government.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
